Ionis Pharmaceuticals Inc (IONS) stock is down -33.26% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives IONS stock a score of 30 out of a possible 100.
That rank is primarily influenced by a long-term technical score of 8. IONS's rank also includes a short-term technical score of 10. The fundamental score for IONS is 72. In addition to the average rating from Wall Street analysts, IONS stock has a mean target price of $49.41. This means analysts expect the stock to rise 56.85% over the next 12 months.
IONS has an Overall Score of 30. Find out what this means to you and get the rest of the rankings on IONS!
Ionis Pharmaceuticals Inc (IONS) stock has gained 4.15% while the S&P 500 has gained 0.68% as of 1:12 PM on Tuesday, Oct 19. IONS has gained $1.25 from the previous closing price of $30.25 on volume of 921,610 shares. Over the past year the S&P 500 has gained 31.80% while IONS is down -33.26%. IONS lost -$3.86 per share in the over the last 12 months.
Click Here to get the full Stock Report for Ionis Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
